docs/_posts/Ahmetemintek/2022-10-12-cvx_code_mapper_en.md
docs/_posts/Ahmetemintek/2022-10-12-cvx_name_mapper_en.md
docs/_posts/Ahmetemintek/2022-10-12-cvx_resolver_pipeline_en.md
docs/_posts/Ahmetemintek/2022-10-12-sbiobertresolve_cvx_en.md
docs/_posts/galiph/2022-10-05-sbiobertresolve_cvx_en.md
docs/_posts/mauro-nievoff/2022-10-01-assertion_oncology_demographic_binary_wip_en.md
docs/_posts/mauro-nievoff/2022-10-01-assertion_oncology_family_history_wip_en.md
docs/_posts/mauro-nievoff/2022-10-01-assertion_oncology_problem_wip_en.md
docs/_posts/mauro-nievoff/2022-10-01-assertion_oncology_response_to_treatment_wip_en.md
docs/_posts/mauro-nievoff/2022-10-01-assertion_oncology_smoking_status_wip_en.md
docs/_posts/mauro-nievoff/2022-10-01-assertion_oncology_test_binary_wip_en.md
docs/_posts/mauro-nievoff/2022-10-01-assertion_oncology_treatment_binary_wip_en.md
docs/_posts/mauro-nievoff/2022-10-01-assertion_oncology_wip_en.md
docs/_posts/mauro-nievoff/2022-10-11-assertion_oncology_demographic_binary_wip_en.md
docs/_posts/mauro-nievoff/2022-10-11-assertion_oncology_family_history_wip_en.md
docs/_posts/mauro-nievoff/2022-10-11-assertion_oncology_problem_wip_en.md
docs/_posts/mauro-nievoff/2022-10-11-assertion_oncology_response_to_treatment_wip_en.md
docs/_posts/mauro-nievoff/2022-10-11-assertion_oncology_smoking_status_wip_en.md
docs/_posts/mauro-nievoff/2022-10-11-assertion_oncology_treatment_binary_wip_en.md
docs/_posts/mauro-nievoff/2022-10-11-assertion_oncology_wip_en.md
docs/_posts/Ahmetemintek/2022-10-12-cvx_code_mapper_en.md
docs/_posts/Ahmetemintek/2022-10-12-cvx_name_mapper_en.md
docs/_posts/Ahmetemintek/2022-10-12-cvx_resolver_pipeline_en.md
docs/_posts/Ahmetemintek/2022-10-12-sbiobertresolve_cvx_en.md
docs/_posts/galiph/2022-10-05-sbiobertresolve_cvx_en.md
docs/_posts/mauro-nievoff/2022-10-01-assertion_oncology_demographic_binary_wip_en.md
docs/_posts/mauro-nievoff/2022-10-01-assertion_oncology_family_history_wip_en.md
docs/_posts/mauro-nievoff/2022-10-01-assertion_oncology_problem_wip_en.md
docs/_posts/mauro-nievoff/2022-10-01-assertion_oncology_response_to_treatment_wip_en.md
docs/_posts/mauro-nievoff/2022-10-01-assertion_oncology_smoking_status_wip_en.md
docs/_posts/mauro-nievoff/2022-10-01-assertion_oncology_test_binary_wip_en.md
docs/_posts/mauro-nievoff/2022-10-01-assertion_oncology_treatment_binary_wip_en.md
docs/_posts/mauro-nievoff/2022-10-01-assertion_oncology_wip_en.md
docs/_posts/mauro-nievoff/2022-10-11-assertion_oncology_demographic_binary_wip_en.md
docs/_posts/mauro-nievoff/2022-10-11-assertion_oncology_family_history_wip_en.md
docs/_posts/mauro-nievoff/2022-10-11-assertion_oncology_problem_wip_en.md
docs/_posts/mauro-nievoff/2022-10-11-assertion_oncology_response_to_treatment_wip_en.md
docs/_posts/mauro-nievoff/2022-10-11-assertion_oncology_smoking_status_wip_en.md
docs/_posts/mauro-nievoff/2022-10-11-assertion_oncology_treatment_binary_wip_en.md
docs/_posts/mauro-nievoff/2022-10-11-assertion_oncology_wip_en.md
